Hartford Great Health Corp.
HFUS · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $330 | $835 | $355 | $378 |
| % Growth | -60.4% | 135.3% | -6.1% | – |
| Cost of Goods Sold | $0 | $3 | $0 | $0 |
| Gross Profit | $330 | $835 | $355 | $378 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $216 | $161 | $170 | $201 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $216 | $161 | $170 | $201 |
| Operating Income | $114 | $671 | $185 | $177 |
| % Margin | 34.5% | 80.4% | 52.1% | 46.8% |
| Other Income/Exp. Net | -$7 | $3 | $2 | $43 |
| Pre-Tax Income | $107 | $675 | $187 | $220 |
| Tax Expense | $57 | -$62 | $96 | $76 |
| Net Income | $51 | $737 | $91 | $144 |
| % Margin | 15.3% | 88.3% | 25.6% | 38.1% |
| EPS | 0.002 | 0.029 | 0.001 | 0.001 |
| % Growth | -93.2% | 3,166.7% | -35.7% | – |
| EPS Diluted | 0.002 | 0.029 | 0.001 | 0.001 |
| Weighted Avg Shares Out | 25,027 | 25,027 | 100,108 | 100,108 |
| Weighted Avg Shares Out Dil | 25,027 | 25,027 | 100,108 | 100,108 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$2 | $2 | $0 |
| Interest Expense | $2 | $2 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $110 | $676 | $185 | $220 |
| % Margin | 33.2% | 81% | 52.1% | 58.2% |